Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2026-02-23 @ 8:30 PM
Study NCT ID:
NCT02412735
Status:
COMPLETED
Last Update Posted:
2022-10-19
First Post:
2015-03-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain
Sponsor:
Mesoblast, Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Degenerative Disc Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Chronic Lumbar Back Pain | View |
| None | Low back pain | View |
| None | Back pain | View |
| None | Degenerative Disc Disease | View |
| None | Injection of Degenerated Lumbar Disc | View |
| None | Intervertebral Disc Degeneration | View |
| None | Bone Diseases | View |
| None | Musculoskeletal Diseases | View |
| None | Nervous System Diseases | View |
| None | Neurologic Manifestations | View |
| None | Pain | View |
| None | Spinal Diseases | View |
| None | Stem Cells | View |
| None | Adult Stem Cells | View |
| None | Allogeneic Mesenchymal Precursor cells (MPCs) | View |
| None | Mesoblast | View |
| None | Hyaluronic Acid | View |
| None | Pharmaceutical Solutions | View |
| None | Adjuvants, Immunologic | View |
| None | Immunologic Factors | View |
| None | Pharmacologic Actions | View |
| None | Protective Agents | View |
| None | rexlemestrocel-L | View |
| None | Viscosupplements | View |